Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 28 | SFEBES2012 | Next issue

Society for Endocrinology BES 2012

Poster Presentations

Thyroid

PBF is a novel regulator of the thyroid hormone transporter MCT8
1School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom; 2Laboratory of Comparative Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium.
ea0028p334
Successful treatment of hyperthyroidism is associated with significant risks of becoming overweight or obese
School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom.
ea0028p335
Management of thyroid dysfunction in pregnant women in tayside, scotland: the thyroid epidemiology, audit and research study (Tears)
1Division of Population Health Science, University of Dundee, Dundee, United Kingdom; 2Medical Research Institute, University of Dundee, Dundee, United Kingdom; 3Maternal and Child Health Sciences, Ninewells Hospital and Medical School, Dundee, United Kingdom.
ea0028p336
Higher thrombus burden in patients with subclinical hypothyroidism after non ST elevation acute coronary syndrome
1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; 2Cardiology, Newcastle upon Tyne Hospitals NHS foundation trust, Newcastle upon Tyne, United Kingdom; 3Endocrinology, Gateshead Health NHS foundation trust, Gateshead, United Kingdom; 4Cardiology, The Mount Sinai Medical Centre, New York, NY.
ea0028p337
PBF interacts with cortactin and thyroglobulin in thyroid cells
1Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom; 2Otolaryngology, Head and Neck Surgery, University Hospital Birmingham, Birmingham, United Kingdom; 3Endocrinology, University Hospital Birmingham, Birmingham, United Kingdom; 4Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.
ea0028p338
The PI3K and HIF pathways promote radio-resistance in thyroid-carcinoma
1Hypoxia and Therapeutics Group, School of Pharmacy, University of Manchester, Manchester, United Kingdom; 2Experimental and Clinical Endocrinology, Med Clinic I - University of Luebeck, Luebeck, Germany.
ea0028p339
Targeted hPTTG overexpression in vivo reduces thyroidal growth and thyroid cell proliferation.
IBR Level 2, Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom.
ea0028p340
The negative psycho-social impact of moderately active Thyroid Eye Disease
1Centre for Appearance Research, University of the West of England, Bristol, United Kingdom; 2Department of Clinical Sciences, Bristol Eye Hospital, Bristol, United Kingdom.
ea0028p341
Orbital decompression for graves' orbitopathy in england
1Endocrinology, Royal Vicoria Infirmary, Newcastle upon Tyne, United Kingdom; 2BTF, British Thyroid Foundation, Harrogate, United Kingdom; 3Centre for Endocrine and Diabetes Sciences, Cardiff Unversity, Cardiff, United Kingdom; 4Ophthalmology, Royal Victoria Infirmary, Newcastle, United Kingdom; 5Ophthalmology, Ninewells Hospital, Dundee, United Kingdom; 6TEDct, Thyroid Eye Disease Charitable Trust, Bristol, United Kingdom; 7Ophthalmology, Moorfields Eye Hospital, London, United Kingdom; 8Endocrinology, Devon and Exeter Hospital, Exeter, United Kingdom.
ea0028p342
Evaluation of adjuvant lithium treatment in patients receiving radioactive iodine for hyperthyroidism: a retrospective cohort study
1Section of Investigative Medicine, Imperial College, London, United Kingdom; 2Imperial Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
ea0028p343
Second course of anti-thyroid treatment may be suitable for some individuals with relapsed Graves' disease.
Department of Endocrinology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
ea0028p344
Outcome after thyroid surgery - patients' perspective
Endocrine Surgery, John Radcliffe Hospital, Oxford, United Kingdom.
ea0028p345
Investigation of thyroglobulin antibody assay discordance
Department of Medical Biochemistry & Immunology, University Hospital of Wales, Cardiff, United Kingdom.
ea0028p346
Rheumatoid Factor interference in TSH assays
1Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, United Kingdom; 2Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
ea0028p347
Post-radioiodine management of patients with Graves' disease
1Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom; 2Medical Physics, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
ea0028p348
TSHoma: a heterogeneous condition requiring multidisciplinary management.
Endocrine Unit, Southend University Hospital, Southend-On-Sea, United Kingdom.
ea0028p350
TBII at discontinuation of ATD therapy as a predictor of relapse of hyperthyroidism in Graves' disease - a prospective analysis
1Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, United Kingdom; 2Department of Clinical Biochemistry, Queen Elizabeth Hospital, Gateshead, United Kingdom.
ea0028p351
Does quantitative measurement of radioiodine (RAI) uptake on the post-high dose RAI whole body scan (WBS) predict residual disease in thyroid cancer following total thyroidectomy?
1Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; 2Department of Nuclear Medicine, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
ea0028p353
Unexpectedly low Thy3 rates in a dedicated one stop thyroid lump clinic
1Diabetes and Endocrinology, Norfolk and Norwich University hospital NHS Foundation Trust, Norwich, United Kingdom; 2Radiology department, Norfolk and Norwich University hospital NHS Foundation Trust, Norwich, United Kingdom; 3Histopathology department, Norfolk and Norwich University hospital NHS Foundation Trust, Norwich, United Kingdom.
ea0028p354
Unusual cause of elevated TSH levels in a treated primary hypothyroidism
Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom.
ea0028p355
The long-term management of thyrotoxicosis with antithyroid drugs
1Diabetes and Endocrinology, Morriston Hospital, Swansea, United Kingdom.
ea0028p356
Five-year review of the management of Graves' thyrotoxicosis
Diabetes & Endocrinology, James Cook University Hospital, Middlesbrough, United Kingdom.
ea0028p357
Assessment of surgical and histological outcome of grade THY3 thyroid fine needle aspiration cytology
1Department of Endocrinology, James Cook University Hospital, Middlesbrough, United Kingdom; 2Department of Cellular Pathology, James Cook University Hospital, Middlesbrough, United Kingdom.
ea0028p358
Hypothyroidism treated with intramuscular thyroxine injections
1Diabetes and Endocrinology, Warrington and Halton Hospitals NHS Foundation Trust, Warrington, United Kingdom.
ea0028p359
Predicting risk of relapse following thionamide withdrawal in Graves' disease
Edinburgh Centre for Endocrinology, Edinburgh, United Kingdom.
ea0028p360
Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease
1Department of Endocrinology & Metabolic Diseases, The Medical University of Lodz & “Polish Mother” Memorial Research Institute, Lodz, Poland; 2Department of Endocrinology and Nuclear Medicine, Hollycross Cancer Centre, Kielce, Poland.
ea0028p361
Hyperthyroidism in Children 5-18 years age. Review of results
Endocrinology, Park Clinic, Kolkata, India.
ea0028p362
Secondary hypothyroidism with silent thyroiditis - A Case Report
Dept of Endocrinology & Diabetes, Hull Royal Infirmary, Hull, United Kingdom.
ea0028p365
To evaluate the efficacy of radioiodine treatment for thyrotoxicosis (555 MBq)
Endocrinology, Lancashire Teaching Hospital, Chorley, United Kingdom.
ea0028p366
Fixed drug eruption in the endocrine clinic: rare presentation of reaction to carbimazole
1Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic science, Addenbrooke's Hospital, Cambridge, United Kingdom; 2Cambridge University, Cambridge, United Kingdom; 3Metabolic Research Laboratories, Cambridge, United Kingdom.
ea0028p367
An audit on the management of hypothyroidism in pregnancy
1Department of Endocrinology, Lancashire Teaching Hospitals NHS Trust, Preston, United Kingdom; 2Department of Obstetrics & Gynaecology, Lancashire Teaching Hospitals NHS Trust, Preston, United Kingdom.
ea0028p368
Management of persistent TSH elevation in hypothyroid patients
Endocrinology Unit, Singleton Hospital, Swansea, United Kingdom.
ea0028p369
Acute bulbar palsy in association with Graves thyrotoxicosis
Endocrine Unit, Hammersmith Hospital, Imperial College London, London, United Kingdom.
ea0028p370
Audit of the management of hypothyroidism in pregnancy: the importance of early testing to optimise treatment
Diabetes and Endocrinology, Barnsley District general Hospital, Barnsley, United Kingdom.
ea0028p371
Langerhans cell histiocytosis and Graves' disease
Endocrine Unit, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom.
ea0028p372
Testicular choriocarcinoma: a rare case of thyrotoxicosis arising as a paraneoplastic syndrome
Endocrinology and Diabetes, Altnagelvin hospital, Londonderry, United Kingdom.
ea0028p373
A rare case of periodic hypokalaemic paralysis secondary to Graves' thyrotoxicosis
Endocrinology, Charing Cross Hospital, Imperial College NHS Healthcare Trust, London, United Kingdom.
ea0028p374
Hypercalcaemia and weight loss does not always equal malignancy
Department of Diabetes and Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
ea0028p375
Comparison of existing practice of FNA cytology in thyroid nodules against the standards
Endocrine, North Manchester General Hospital, Manchester, United Kingdom.
ea0028p376
Radioiodine treatment for thyrotoxicosis in a district hospital: An audit and patient satisfaction survey
Department of Endocrinology, Peterborough City Hospital, Peterborough, United Kingdom.
ea0028p377
The spectrum of presentations of hypothyroidism in primary care
1Shadbolt Park House Surgery, Worcester Park, United Kingdom; 2Department of Endocrinology, St Helier Hospital, Carshalton, United Kingdom.
ea0028p378
'Resistant' hypothyroidism - rare causes to consider
BDEC, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
ea0028p379
Alemtuzamab induced thyrotoxicosis
Endocrine Unit, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom.
ea0028p381
Removal of heterophilic antibody interference in thyroid function tests with heterophilic blocking tubes
Laboratory Medicine, University Hospital Southampton, Southampton, United Kingdom.
ea0028p382
A case of hyperthyroidism presenting with cholestasis
1Endocrinology, Erne hospital, Enniskillen, United Kingdom.
ea0028p383
Audit of one stop thyroid nodule clinic
Diabetes and Endocrinology, East Surrey Hospital, Redhill, United Kingdom.
ea0028p384
T4 mono-therapy versus T4/T3 combination therapy: a local review
Department of Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
ea0028p385